Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Excess mortality in England and Wales during the first wave of the COVID-19 pandemic

View ORCID ProfileEvangelos Kontopantelis, View ORCID ProfileMamas A Mamas, View ORCID ProfileJohn Deanfield, View ORCID ProfileMiqdad Asaria, Tim Doran
doi: https://doi.org/10.1101/2020.05.26.20113357
Evangelos Kontopantelis
1Division of Informatics, Imaging and Data Science, University of Manchester, Manchester, England
2NIHR School for Primary Care Research, University of Oxford, Oxford, England
PhD.
Roles: Professor in Data Science and Health Services Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evangelos Kontopantelis
  • For correspondence: e.kontopantelis{at}manchester.ac.uk
Mamas A Mamas
1Division of Informatics, Imaging and Data Science, University of Manchester, Manchester, England
3Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, England
4Department of Cardiology, Jefferson University, Philadelphia, USA
BMBCh DPhil MA FRCP
Roles: Professor of Cardiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mamas A Mamas
John Deanfield
5Institute of Cardiovascular Science, University College Hospital, London, England
BA Hons (Canteb), BChir MB, MRCP, FRCP, BHF
Roles: Vandervell Chair of Cogenital Heart Disease
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John Deanfield
Miqdad Asaria
6Department of Health Policy, London School of Economics and Political Science, London, England
PhD
Roles: Assistant Professorial Research Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miqdad Asaria
Tim Doran
7Department of Health Sciences, University of York, England
MD.
Roles: Professor of Health Policy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Deaths during the COVID-19 pandemic result directly from infection and exacerbation of other diseases and indirectly from deferment of care for other conditions, and are socially and geographically patterned. We quantified excess mortality in regions of England and Wales during the pandemic, for all causes and for non-COVID-19 associated deaths.

Methods Weekly mortality data for 1 Jan 2010 to 1 May 2020 for England and Wales were obtained from the Office of National Statistics. Mean-dispersion negative binomial regressions were used to model death counts based on pre-pandemic trends and exponentiated linear predictions were subtracted from: i) all-cause deaths; and ii) all-cause deaths minus COVID-19 related deaths for the pandemic period (07-13 March to 25 April to 8 May).

Findings Between 7 March and 8 May 2020, there were 47,243 (95%CI: 46,671 to 47,815) excess deaths in England and Wales, of which 9,948 (95%CI: 9,376 to 10,520) were not associated with COVID-19. Overall excess mortality rates varied from 49 per 100,000 (95%CI: 49 to 50) in the South West to 102 per 100,000 (95%CI: 102 to 103) in London. Non-COVID-19 associated excess mortality rates ranged from −1 per 100,000 (95%CI: −1 to 0) in Wales (i.e. mortality rates were no higher than expected) to 26 per 100,000 (95%CI: 25 to 26) in the West Midlands.

Interpretation The COVID-19 pandemic has had markedly different impacts on the regions of England and Wales, both for deaths directly attributable to COVID-19 infection and for deaths resulting from the national public health response.

Funding None

What is already known on the subject

  1. The number of deaths due to COVID-19 have been quantified by the Office of National Statistics

  2. These have also been reported across age groups and regions

What this study adds

  1. We report the number of excess deaths, using weekly mortality data from 1/1/2010

  2. We also quantify the number of excess deaths, excluding COVID-19 associated deaths, which can be attributed to COVID-19 directly (but not coded as such) or indirectly (due to other urgent but unmet health need)

  3. Highest excess mortality, excluding COVID-19 deaths, was observed in the West Midlands, followed by London and the North West

  4. Although males had larger excess mortality rates than females across all age groups, female excess mortality rates excluding COVID-19 were higher in the 85+ age group, indicating a large undocumented impact of the virus on older females (direct and/or indirect)

  5. The three provided appendices will be updated weekly on the BMJ-JECH website, to provide up-to-date information of excess mortality by region, sex and age group

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This is a study based on publicly available official government mortality data

Funding Statement

No external funding was received for this study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study is based on publicly available official government mortality statistics and hence did not require specific ethics approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used in the study is publicly available from the UK Office for National Statistics

https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Excess mortality in England and Wales during the first wave of the COVID-19 pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Excess mortality in England and Wales during the first wave of the COVID-19 pandemic
Evangelos Kontopantelis, Mamas A Mamas, John Deanfield, Miqdad Asaria, Tim Doran
medRxiv 2020.05.26.20113357; doi: https://doi.org/10.1101/2020.05.26.20113357
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Excess mortality in England and Wales during the first wave of the COVID-19 pandemic
Evangelos Kontopantelis, Mamas A Mamas, John Deanfield, Miqdad Asaria, Tim Doran
medRxiv 2020.05.26.20113357; doi: https://doi.org/10.1101/2020.05.26.20113357

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)